News

As per the agreement, Roche will provide R&D funding and scientific support to BioLamina. The financial terms and conditions of the deal were undisclosed. Roche’s Biochemical Reagents and

Since 2008, DKSH Healthcare is providing Market Expansion Services to Advance Pharma in West Malaysia. The extended partnership between DKSH and Advance Pharma in Malaysia aims to demonstrate

The approved patent application, which is part of the ‘Pan’ patent family, is designed to restore vision in retinal degenerative conditions such as retinitis pigmentosa and dry age-related

Ajinomoto said based upon a successful proof-of-concept, the company has entered a full licensing agreement that allows for the in-house use of the system. Corynex uses the gram-positive

The licensing agreement provides miRagen with exclusive rights to an important discovery made in collaboration with the University of Glasgow and the University of Cambridge, enabling miRagen to

The agreement aims to manufacture eribulin mesylate as well as other developmental drugs. DSM Pharmaceutical Products president and CEO Alexander Wessels said, "We are delighted to be working

The partnership aims to provide drug developers with improved access to pharmaceutical nanomilling equipment and full pharmaceutical development capabilities. Particle Sciences pharmaceutical development president Robert Lee said the

FDA in the letter mentioned that it requires Mallinckrodt’s complete pharmacokinetic study comparing PENNSAID 2% to original PENNSAID 1.5%. FDA denied to review the similar pharmacokinetic studies submitted

According to the firm, the lower dose submicron diclofenac NDA submission included data from a study conducted on 428 healthy adults in a Phase 3 multi-center, randomized process,